...
机译:纳米宫介导的细胞选择性递送NeoAntigens提高了个性化免疫的养老细胞转移
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res 501 Haike Rd Shanghai 201203 Peoples R China|Chinese Acad Sci Shanghai Inst Mat Medica Ctr Pharmaceut 501 Haike Rd Shanghai 201203 Peoples R China|Yantai Inst Mat Medica Yantai Key Lab Nanomed & Adv Preparat Yantai 264000 Shandong Peoples R China|Univ Chinese Acad Sci Beijing 100049 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res 501 Haike Rd Shanghai 201203 Peoples R China|Chinese Acad Sci Shanghai Inst Mat Medica Ctr Pharmaceut 501 Haike Rd Shanghai 201203 Peoples R China|Yantai Inst Mat Medica Yantai Key Lab Nanomed & Adv Preparat Yantai 264000 Shandong Peoples R China|Univ Chinese Acad Sci Beijing 100049 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res 501 Haike Rd Shanghai 201203 Peoples R China|Chinese Acad Sci Shanghai Inst Mat Medica Ctr Pharmaceut 501 Haike Rd Shanghai 201203 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res 501 Haike Rd Shanghai 201203 Peoples R China|Chinese Acad Sci Shanghai Inst Mat Medica Ctr Pharmaceut 501 Haike Rd Shanghai 201203 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res 501 Haike Rd Shanghai 201203 Peoples R China|Chinese Acad Sci Shanghai Inst Mat Medica Ctr Pharmaceut 501 Haike Rd Shanghai 201203 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res 501 Haike Rd Shanghai 201203 Peoples R China|Chinese Acad Sci Shanghai Inst Mat Medica Ctr Pharmaceut 501 Haike Rd Shanghai 201203 Peoples R China|Yantai Inst Mat Medica Yantai Key Lab Nanomed & Adv Preparat Yantai 264000 Shandong Peoples R China|Univ Chinese Acad Sci Beijing 100049 Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res 501 Haike Rd Shanghai 201203 Peoples R China|Chinese Acad Sci Shanghai Inst Mat Medica Ctr Pharmaceut 501 Haike Rd Shanghai 201203 Peoples R China|Yantai Inst Mat Medica Yantai Key Lab Nanomed & Adv Preparat Yantai 264000 Shandong Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res 501 Haike Rd Shanghai 201203 Peoples R China|Chinese Acad Sci Shanghai Inst Mat Medica Ctr Pharmaceut 501 Haike Rd Shanghai 201203 Peoples R China|Yantai Inst Mat Medica Yantai Key Lab Nanomed & Adv Preparat Yantai 264000 Shandong Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res 501 Haike Rd Shanghai 201203 Peoples R China|Chinese Acad Sci Shanghai Inst Mat Medica Ctr Pharmaceut 501 Haike Rd Shanghai 201203 Peoples R China|Yantai Inst Mat Medica Yantai Key Lab Nanomed & Adv Preparat Yantai 264000 Shandong Peoples R China;
Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res 501 Haike Rd Shanghai 201203 Peoples R China|Chinese Acad Sci Shanghai Inst Mat Medica Ctr Pharmaceut 501 Haike Rd Shanghai 201203 Peoples R China|Univ Chinese Acad Sci Beijing 100049 Peoples R China|Bohai Rim Adv Res Inst Drug Discovery Zhongshan 264000 Shandong Peoples R China|Yantai Univ Sch Pharm Yantai 264005 Shandong Peoples R China;
adoptive cell transfer; cancer immunotherapy; dendritic cells; nanovaccines; neoantigens;
机译:通过下一代测序鉴定肿瘤特异性突变和识别新抗原的肿瘤浸润淋巴细胞的过继转移,从而对非小细胞肺癌进行个性化免疫治疗
机译:骨髓过继转移后抗肿瘤免疫反应的增强,这些骨髓是由经肿瘤裂解物脉冲树突状细胞免疫的供体获得的。
机译:个性化的新洲脉冲树突状细胞疫苗显示出小鼠肿瘤模型中的新南鬣蜥佐剂疫苗的优异免疫原性
机译:用PRRS病毒GP5蛋白脉冲树突细胞的免疫诱导CD4 +但不是CD8 + T细胞
机译:过继转移的淋巴细胞通过CCL5和CD40L信号传导以及树突状细胞耗竭引发内源性抗肿瘤免疫力。
机译:非小细胞肺癌的个性化免疫疗法通过下一代测序鉴定肿瘤特异性突变和识别新抗原的肿瘤浸润淋巴细胞的过继转移
机译:非小细胞肺癌的个性化免疫疗法,通过下一代测序鉴定肿瘤特异性突变和识别新抗原的肿瘤浸润淋巴细胞的过继转移
机译:通过转移的腹膜细胞和小鼠脾细胞形成抗体。 I.将来自免疫的非辐照供体的细胞转移至有和没有抗原的同源受体